RESEARCH & DEVELOPMENT

Eupharma has had extensive involvement and experience for over 20 years in the development of New Pharmaceutical Chemical Entities (NCE’s) and the repositioning of older “known” drugs.

This experience has been translated into a focus on what we believe are key elements for more time and cost effective preparation of a drug registration packages, or either releasing the pharmaceutical to the market, or out licencing it or its API to another Company.

research

Our Services

We offer services in a group of key areas.

assistance

ASSISTANCE

Assistance with the choice of disease to target with a focus on limiting this to a narrower indication to obtain Orphan status and/or seek a clearer objective clinical outcome in trials, or an outcome which can be measured in a shorter period.

API EVALUATION

API evaluation including the salt to be used, solubility, purity, stability, related substances, polymorphs, assay validations etc (patent evaluation).

examination

EXAMINATION

Examination of potential competitive molecules and their state of development, price potential and market value/size.

FORMULATION

Formulation development for the selected dose form, task masking, stability and evaluation of the rationale for dose selection and dosage (patent evaluation).

checklist

ASSESSMENT

Assessment of the proposed final dose form and route of administration in consultation with medical stakeholders (patent evaluation).

EVALUATION cGMP

Evaluation and selection of cGMP manufacturers for the final API and of the final dose form/s.